WHR
72
2
ADT
58
-3
GRMN
71
-2
WU
20
-2
WAT
61
-3
ALLE
53
-4
DFS
73
3
AN
54
2
INTC
48
5
UNP
48
-4
BLK
75
3
PWR
72
-2
FDX
44
-7
MET
63
3
M
31
-5
LUV
48
3
GME
71
6
TRIP
47
-5
MRK
27
-3
DNB
88
2
WHR
72
2
ADT
58
-3
GRMN
71
-2
WU
20
-2
WAT
61
-3
ALLE
53
-4
DFS
73
3
AN
54
2
INTC
48
5
UNP
48
-4
BLK
75
3
PWR
72
-2
FDX
44
-7
MET
63
3
M
31
-5
LUV
48
3
GME
71
6
TRIP
47
-5
MRK
27
-3
DNB
88
2
Financhill
Back

HOOKIPA Pharma Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
14

HOOK
HOOKIPA Pharma

Last Price:
3.54
Seasonality Move:
7.53%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

HOOKIPA Pharma Price Quote

$3.54
-0.14 (-3.88%)
(Updated: November 12, 2024 at 5:40 PM ET)

HOOKIPA Pharma Key Stats

Sell
14
HOOKIPA Pharma (HOOK) is a Sell
Day range:
$3.65 - $3.76
52-week range:
$3.41 - $11.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.84
P/B ratio:
0.42%
Volume:
63.2K
Avg. volume:
41K
1-year change:
-17.38%
Market cap:
$36.4M
Revenue:
$20.1M
EPS:
$-4.32

How Much Does HOOKIPA Pharma Make?

Is HOOKIPA Pharma Growing As A Company?

  • What Is HOOKIPA Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.52%
  • What Is HOOKIPA Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

HOOKIPA Pharma Stock Price Performance

  • Did HOOKIPA Pharma Stock Go Up Last Month?
    HOOKIPA Pharma share price went down by -0.73% last month
  • Did HOOK's Share Price Rise Over The Last Year?
    HOOK share price fell by -17.38% over the past 1 year

What Is HOOKIPA Pharma 52-Week High & Low?

HOOKIPA Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy HOOKIPA Pharma?

  • How Much Debt Does HOOKIPA Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does HOOKIPA Pharma Have?
    Cash and short term investments quarterly total is $77.2M
  • What Is HOOKIPA Pharma’s Book Value Per Share?
    Book value per share is 8.70

Is HOOKIPA Pharma Cash Flow Positive?

  • What Is HOOK Cash Flow From Operations?
    Cash flow from operations (TTM) is -$73.9M
  • What Is HOOKIPA Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $19.3M
  • What Is HOOKIPA Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.6M

HOOKIPA Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    HOOK return on invested capital is -49.37%
  • What Is HOOKIPA Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -30.86%
  • What Is HOOK Return On Equity?
    ROE is a measure of profitability and is -49.81%

HOOKIPA Pharma Earnings Date & Stock Price

HOOKIPA Pharma Competitors

  • Who Are HOOKIPA Pharma's Competitors?
    Below is a list of companies who compete with HOOKIPA Pharma or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

HOOKIPA Pharma Dividend Yield

HOOKIPA Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -21.01%
Revenue: -51.85% -81.81%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 43.50
Upside from Last Price: 1081.1%

Major Shareholders

  • How many HOOK shares are owned by institutional investors?
    65.1M HOOK shares are owned by institutional investors
  • How many HOOK shares are owned by insiders?
    637.3K HOOK shares are owned by insiders